Brief: China NT Pharma Group Posts FY Loss Attributable Of RMB357.6 Mln
31/03/2021 16:21
March 31 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* FY REVENUE FROM CONTINUING OPERATIONS RMB221.7 MILLION
VERSUS
RMB153.5 MILLION
* FY LOSS ATTRIBUTABLE RMB357.6 MILLION VERSUS LOSS OF
RMB587.6
MILLION
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0331/2021033102818.pdf
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY